Prostate Cancer: Dissatisfaction With Current Diagnostics Drives Interest In Innovation

The lack of accurate tools for diagnosing the severity of prostate cancer creates opportunities for start-ups with novel approaches. Profiles of 3D Biopsy, Blue Earth Diagnostics, UroSens, and Prostate Management Diagnostics.

More from Archive

More from Medtech Insight